IPO - Endeavour Medtech Growth II LP

Form Type: SCHEDULE 13G

Filing Date: 2025-05-15

Corporate Action: Ipo

Type: New

Accession Number: 000095017025072595

Filing Summary: Endeavour Medtech Growth II LP, along with its associated entities, has filed a Schedule 13G indicating their ownership in Kestra Medical Technologies, Ltd. as of March 31, 2025. The document outlines that Endeavour Medtech Growth II LP holds 972,077 Common Shares directly and has a beneficial interest in 1,628,023 Common Shares via West Affum Holdings, L.P., which is involved in a Post-IPO Distribution agreement related to the Issuer's upcoming initial public offering. This filing includes details on the distribution of shares and the voting rights associated with the held shares, noting that while the Reporting Persons are entitled to direct the votes of the shares held through West Affum, they lack dispositive power over these shares. The ownership percentages calculated are based on a reported 51,348,656 Common Shares outstanding as of April 17, 2025. The document confirms the list of Reporting Persons, the nature of their ownership, and the conditions under which they’re entitled to receive the shares from West Affum Holdings, L.P.